Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin: The 26-Week Interventional, single-arm ARTEMIS-DM study
Introduction The efficacy and safety of switching to insulin glargine 300 U/mL (Gla-300) in type 2 diabetes mellitus (T2DM) uncontrolled on basal insulin (BI) has been demonstrated in the North American and Western European populations; however, there is limited data from other geographical regions...
Saved in:
Main Authors: | Sethi, Bipin, Al-Rubeaan, Khalid, Unubol, Mustafa, Mabunay, Maria A., Berthou, Baptiste, Pilorget, Valerie, Vethakkan, Shireene R., Frechtel, Gustavo |
---|---|
Format: | Article |
Published: |
Springer Heidelberg
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41913/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin Glargine in the intensive care unit: A model-based clinical trial design
by: Willis, J.G., et al.
Published: (2018) -
Glargine as a basal insulin supplement in recovering critically ill patients - An in silico study
by: Razak, N.N., et al.
Published: (2018) -
The effect of Glargine as basal insulin support for recovering critically ill and high dependency unit patients: An in silico study
by: Lin, J., et al.
Published: (2018) -
Improved second phase insulin secretion and preserved insulin sensitivity after islet transplantation
by: Vethakkan, S.R., et al.
Published: (2010) -
Patient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitus
by: Ng, Chirk Jenn, et al.
Published: (2018)